The Cancer Letter

Inside information on cancer research and drug development

In Brief

Young Investigator Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Molecular and immune profiling of acral melanoma from various ethnicities

MRA Young Investigator Award, collaboratively funded by University of Texas MD Anderson Cancer Center, 2018-2021

  • Phyu Aung, University of Texas MD Anderson Cancer Center

Building a predictive framework for vaccine design against melanoma

Elliott and Ruth Sigal-MRA Young Investigator Award, 2018-2021

  • Nicolas Chevrier, The University of Chicago

Manipulating cellular metabolism to promote cancer immunity in melanoma

The Robbins Family-MRA Young Investigator Award, 2018-2021

  • Ku-Lung Hsu, The University of Virginia

Investigating the mechanistic basis for tumor immunogenicity in melanoma

The Sokoloff Family-MRA Young Investigator Award, 2018-2021

  • Nikhil Joshi, Yale University

LncRNAs as modulators of protein synthesis rewiring in melanoma

Amanda and Jonathan Eilian-MRA Young Investigator Award, 2018-2021

  • Eleonora Leucci, Katholieke Universiteit Leuven

Primary anogenital melanoma: Comprehensive molecular and immune analysis

MRA Young Investigator Award, collaboratively funded by University of Texas MD Anderson Cancer Center, 2018-2021

  • Priyadharsini Nagarajan, University of Texas MD Anderson Cancer Center

Isoform-specific targeting of the PI3Ks to overcome cancer immunoresistance

MRA Young Investigator Award, collaboratively funded by University of Texas MD Anderson Cancer Center, 2018-2021

  • Weiyi Peng, University of Texas MD Anderson Cancer Center

Dependence of melanoma metastasis on AMPK-mediated metabolic switch

Ellen and Gary Davis Foundation-MRA Young Investigator Award, collaboratively funded by Joan & Sanford I. Weill Medical College of Cornell University, 2018-2021

  • Elena Piskounova, Joan & Sanford I. Weill Medical College of Cornell University

The genomic landscape of individual melanocytes from human skin

Tara Miller Melanoma Foundation-MRA Young Investigator Award, 2018-2021

  • A. Hunter Shain, The University of California, San Francisco

A novel approach for NF1 mutant melanoma sub-classification

MRA Young Investigator Award, 2018-2021

  • Edward Stites, The Salk Institute for Biological Studies

Targeting PSGL-1 inhibitory pathways to promote anti-tumor T cell immunity

The Denise and Michael Kellen Foundation-MRA Young Investigator Award, 2018-2021

  • Roberto Tinoco, Sanford Burnham Prebys Medical Discovery Institute

Pilot study of intervention to reduce sunburns in melanoma survivors

The Wayne Stinchcomb Big Orange Foundation-MRA Young Investigator Award for Women in Scientific Research, 2018-2021

  • Rachel Vogel, The University of Minnesota – Twin Cities

Targeting the JNK-ITCH signaling pathway in melanoma

Mary Jo and Brian Rogers-MRA Young Investigator Award, 2018-2021

  • Lixin Wan, H. Lee Moffitt Cancer Center & Research Institute

Developing advanced non-invasive histology techniques

Brownstein, Hyatt, Farber & Schreck-MRA Young Investigator Award, 2018-2021

  • Jesse Wilson, Colorado State University

Targeting BRAF/NRAS wildtype melanoma with ERBB3 and MEK Inhibition

Julie and Edward J. Minskoff-MRA Young Investigator Award, collaboratively funded by New York University School of Medicine, 2018-2021

  • Melissa Wilson, New York University School of Medicine

Table of Contents

YOU MAY BE INTERESTED IN

White House

Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
By Paul Goldberg
Capitol Hill

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate
The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
By Claire Marie Porter
Guest Editorial

Cancer research fuels life-saving work

Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 
By Ze’ev Ronai
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account